Navigation Links
MAP Pharmaceuticals Reports 2009 Fourth Quarter and Year End Financial Results
Date:3/2/2010

ew pipeline opportunities by applying its proprietary drug particle and inhalation technologies to enhance the therapeutic benefits of proven drugs, while minimizing risk by capitalizing on their known safety, efficacy and commercialization history.

Additional information about MAP Pharmaceuticals can be found at http://www.mappharma.com.

Forward-Looking Statements

In addition to statements of historical facts or statements of current conditions, this press release contains forward-looking statements, including with respect to MAP Pharmaceuticals' LEVADEX product candidate, and MAP Pharmaceuticals' expected cash requirements during 2010 described above.  Actual results may differ materially from current expectations based on risks and uncertainties affecting the company's business, including, without limitation, risks and uncertainties relating to the enrollment, conduct and completion of clinical trials, failure to achieve favorable clinical outcomes and to have the company's LEVADEX product candidate approved for commercial use and risks related to MAP Pharmaceuticals' future financial results. The reader is cautione
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Alexza Pharmaceuticals to Present at the Cowen and Company 30th Annual Health Care Conference
2. DUSA Pharmaceuticals, Inc.(R) to Host Fourth Quarter and Full Year 2009 Financial Results and Corporate Highlights Conference Call
3. Thomas Pharmaceuticals, Ltd to Merge with Global Medical Equipment of AZ
4. Abbott Completes Acquisition of Solvay Pharmaceuticals
5. Biostar Pharmaceuticals, Inc. Announces Change of Auditor
6. Lotus Pharmaceuticals Announces Key Changes
7. Genetix Pharmaceuticals' Adrenoleukodystrophy (ALD) Product Recognized As One of Science Magazine's Top 10 Scientific Breakthroughs of 2009
8. Hospira to Acquire Orchids Generic Injectable Pharmaceuticals Business
9. Amylin Pharmaceuticals to Present at the 2009 Deutsche Bank Biotech Boston Confab
10. PD-Rx Pharmaceuticals, Inc. Reports 1st Quarter Earnings
11. Onyx Pharmaceuticals Announces December 2009 Investor Events
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... July 29, 2015 , ... Gender ... inequities. Since 2012, Massachusetts law has provided legal protections against discrimination on the ... law does not protect against discrimination based on gender identity in places open ...
(Date:7/29/2015)... ... 29, 2015 , ... Potomac Pilates, an elite Washington, D.C. metro area-based Pilates ... Reformer ® by Potomac Pilates. On Thursday, July 30, Potomac Pilates will unveil ... by Potomac Pilates will continue to offer the same classes and personal experiences their ...
(Date:7/29/2015)... ... July 29, 2015 , ... More than 28,000 students ... of children living with autism will converge upon Penn State to share the ... The National Autism Conference will be held Aug. 3-6 at the Penn Stater ...
(Date:7/29/2015)... , ... July 29, 2015 , ... ... CCM® credential for a five-year period, expiring November 30, 2019, during its recent ... by submitting an application demonstrating the program’s compliance with the NCCA’s Standards for ...
(Date:7/29/2015)... ... July 29, 2015 , ... According to the Miami Herald ... addiction and mental health disorders. Acu-detox may begin taking off in the South Florida ... and alcohol addiction. Although acupuncture is not a new practice, it is not widely ...
Breaking Medicine News(10 mins):Health News:Fenway Health Researcher: Legal Protections in Public Settings are a Critical Public Health Issue for Transgender and Gender-Nonconforming People 2Health News:Fenway Health Researcher: Legal Protections in Public Settings are a Critical Public Health Issue for Transgender and Gender-Nonconforming People 3Health News:Same Great Pilates Studio, New Brand - Rock the Reformer 2Health News:Penn State Conference to Address Instruction, Success for Children with Autism 2Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 2Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 3Health News:Miami Drug Rehab Introduces Acupuncture to Line of Holistic Healing for Addiction 2Health News:Miami Drug Rehab Introduces Acupuncture to Line of Holistic Healing for Addiction 3
... Consulting from Best Medical Spa in America. Raleigh, NC medspa Blue Water ... owners at Medspa conference on October 6, 2008 in Orlando, FL. ... ... Water Spa has been voted Best Medical Spa in America. Medical Spa ...
... inevitable part of aging, but it is strongly related a ... and lifetime experiences, many of which are interrelated, according to ... , The study, funded by the National Institutes of Health, ... an impact on sexual health later in life. People who ...
... Breast cancer patients and their physicians may make more ... help determine probability of recurrence, a research team led ... Anderson Cancer Center reported in the Aug. 12 online ... Institute . , The 2,838 women studied were diagnosed ...
... Inc.,(OTC Bulletin Board: NGNM) today announced that it ... Conference at 1:30 p.m. (Pacific) on,Monday, August 18, ... Nevada., Robert Gasparini, the Company,s President and ... Financial Officer, will give a,23-minute presentation regarding NeoGenomics, ...
... A study by researchers at the University of Southern ... significant risk for pre-diabetes, a condition marked by higher ... high enough for a diagnosis of diabetes. The persistence ... risk towards future diabetes, according to the study, which ...
... Voices for America,s,Children today launched an online campaign ... speak out on the importance of investing in ... development., "Children,s issues must be a priority ... when our children have,adequate health care, quality early ...
Cached Medicine News:Health News:Medical Spa Consulting from Best Medspa in America to Provide Advanced Medical Spa Education at Medspa Conference in Orlando, FL 2Health News:Medical Spa Consulting from Best Medspa in America to Provide Advanced Medical Spa Education at Medspa Conference in Orlando, FL 3Health News:Causes for sexual dysfunction change as people age 2Health News:Risk assessment plays key role in long-term treatment of breast cancer 2Health News:NeoGenomics to Present at the Noble Financial Equity Conference 2Health News:Overweight Hispanic children at significant risk for pre-diabetes, according to new USC study 2Health News:VOICES Launches 'Vote Kids 2008' to Engage Voters and Candidates in Shaping National Policies for America's Children 2
(Date:7/29/2015)... 29, 2015  Nektar Therapeutics (Nasdaq: NKTR ) will ... 30, 2015 on Wednesday, August 5, 2015, after the close ... chief executive officer, will host a conference call to review ... Pacific Time (PT). The press release and ... accessed through a link that is posted on the home ...
(Date:7/29/2015)... WASHINGTON , July 29, 2015  According to ... Medicaid Services, the 2016 average monthly Medicare Part D ... figure far lower than was originally projected, the Pharmaceutical ... Part D program continues to be a bright spot ... competing choices in each region and using cutting edge, ...
(Date:7/29/2015)... and BERKELEY, Calif. , July 29, ... a member of the Daiichi Sankyo Group, announced today ... published clinical trial results demonstrating that the investigational ... tumor regressions in most patients with tenosynovial giant cell ... joint or tendon sheath. Following phase 1 ...
Breaking Medicine Technology:Nektar to Announce Financial Results for the Second Quarter 2015 on Wednesday, August 5, 2015, After Close of U.S.-Based Financial Markets 2Nektar to Announce Financial Results for the Second Quarter 2015 on Wednesday, August 5, 2015, After Close of U.S.-Based Financial Markets 3Daiichi Sankyo and Plexxikon Announce Study Published in NEJM Demonstrates PLX3397 Induced Prolonged Tumor Regression in Tenosynovial Giant Cell Tumor (TGCT) in Most Patients 2Daiichi Sankyo and Plexxikon Announce Study Published in NEJM Demonstrates PLX3397 Induced Prolonged Tumor Regression in Tenosynovial Giant Cell Tumor (TGCT) in Most Patients 3Daiichi Sankyo and Plexxikon Announce Study Published in NEJM Demonstrates PLX3397 Induced Prolonged Tumor Regression in Tenosynovial Giant Cell Tumor (TGCT) in Most Patients 4Daiichi Sankyo and Plexxikon Announce Study Published in NEJM Demonstrates PLX3397 Induced Prolonged Tumor Regression in Tenosynovial Giant Cell Tumor (TGCT) in Most Patients 5
... ATLANTA, April 26, 2012 UCB today announced interim ... added to O ne B aseline ... refractory partial-onset seizures treated with Vimpat® (lacosamide) C-V as add-on ... today at the 64th annual meeting of the American ...
... International, Inc. (NASDAQ: CHDX ), an American ... through the operations of United Family Healthcare, a network ... today announced that the Company plans to release financial ... 31, 2012 on Wednesday, May 9, 2012, after the ...
Cached Medicine Technology:Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology 2Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology 3Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology 4Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology 5Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology 6Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology 7Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology 8Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology 9Chindex International, Inc. to Report First Quarter 2012 Financial Results 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: